BIO-key International (NASDAQ:BKYI) Shares Pass Below 50 Day Moving Average – Here’s Why

BIO-key International Inc. (NASDAQ:BKYI)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $5.47 and traded as low as $4.25. BIO-key International shares last traded at $4.40, with a volume of 5,038 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research note on Monday, April 20th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

BIO-key International Stock Performance

The company has a market cap of $4.77 million, a PE ratio of -0.63 and a beta of 0.45. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. The company has a 50-day moving average of $5.47 and a 200-day moving average of $6.33.

BIO-key International (NASDAQ:BKYI) last announced its earnings results on Tuesday, March 31st. The technology company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.70) by $0.51. The company had revenue of $1.24 million for the quarter, compared to analysts’ expectations of $2.20 million. BIO-key International had a negative return on equity of 67.43% and a negative net margin of 75.32%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC lifted its stake in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 26.51% of the company’s stock.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.